Pharma
28 views | +0 today
Follow
Your new post is loading...
Your new post is loading...
Rescooped by Cindy Cárdenas from Health Care Social Media And Digital Health
Scoop.it!

Crowdsourced health studies

Crowd Sourced Health Care Studies:Implications for PharmaDavid Lee Scher, MD, FACC, FHRSDigitalhealthconsultants.com

Via Marie Ennis-O'Connor
more...
No comment yet.
Rescooped by Cindy Cárdenas from Digital, innovation et santé !
Scoop.it!

Top 10 Pharma Efforts in Socia Media

A Report by JD Lasica; Socialmedia.biz; jd@socialmedia.biz

Via Matthieu BOYER
more...
No comment yet.
Rescooped by Cindy Cárdenas from Doctor
Scoop.it!

How to make the most of a medical conference: a personal reflection on EULAR 2013

How to make the most of a medical conference: a personal reflection on EULAR 2013 | Pharma | Scoop.it

Dr. Philip Gardiner (@PhilipGardiner) writes:

 

I have just returned from the annual European Rheumatology EULAR 2013 (#EULAR2013) meeting in Madrid. This massive conference was attended by about 14,000 delegates, with over 500 ‘posters’ per day and over 230 invited speakers. There were 10 concurrent oral sessions in the programme 4 or 5 times a day, often with very little time in between.

 

I can remember many conferences in the past where I felt that I hadn’t get much out of the conference, but I think that this one was better than most. Over the years I have learned that it takes a lot of preparation and focus to make the most of the experience. For what it’s worth, I’m going to share with you how a I went about my preparation this.


Via Andrew Spong
more...
Andrew Spong's curator insight, June 19, 2013 3:25 AM

This exemplary post is a great primer for healthcare professionals looking to use social media effectively at congresses. Highly recommended.

Deborah Verran's comment, June 19, 2013 5:56 AM
Great blog post. Shared via Google+
Rescooped by Cindy Cárdenas from Pharma & Medical Devices
Scoop.it!

Which mHealth Apps Are Doctors Prescribing?

Which mHealth Apps Are Doctors Prescribing? | Pharma | Scoop.it
This week, HealthTap, a fast-growing mobile health platform that connects users with a network of more than 40,000  doctors - rolled out something called

Via Richard Meyer
more...
Tony Hardman's curator insight, June 18, 2013 5:23 PM

Healthcare Interrupted -
Top Five Vulnerabilities Hackers Can Use Right Now To Shut Down Medical Devices http://bit.ly/12TDPR5

Rescooped by Cindy Cárdenas from Pharma & Medical Devices
Scoop.it!

Infographic: Is Cyberchrondria the Darkside of Digital Health?

Infographic: Is Cyberchrondria the Darkside of Digital Health? | Pharma | Scoop.it
Is the rise of digital health tools such as mobile health, telehealth, and remote patient monitoring creating a new nation of cyberchondriacs?

Via Richard Meyer
more...
Tony Hardman's curator insight, June 18, 2013 5:22 PM

Healthcare Interrupted -
Top Five Vulnerabilities Hackers Can Use Right Now To Shut Down Medical Devices http://bit.ly/12TDPR5

Rescooped by Cindy Cárdenas from Digitized Health
Scoop.it!

FDA clears GlobalMed's medical imaging cloud software - mobihealthnews

mobihealthnews FDA clears GlobalMed's medical imaging cloud software mobihealthnews GlobalMed CapSure Cloud Scottsdale, Arizona-based GlobalMed, a maker of connected health devices and software platforms, received FDA 510(k) clearance for its...

Via Emmanuel Capitaine
more...
No comment yet.
Rescooped by Cindy Cárdenas from Drugs, Society, Human Rights & Justice
Scoop.it!

Tools for Starting a Naloxone Program

Tools for Starting a Naloxone Program | Pharma | Scoop.it

Naloxone is an easy-to-use, lifesaving antidote to overdose from heroin or other opioids. Used in hospitals for decades, the medication has no abuse potential, costs as little as one dollar for a lifesaving dose and can be administered with basic training. - See more at: http://naloxoneinfo.org/#sthash.wwkPsEkx.dpuf


Via Julian Buchanan
more...
Julian Buchanan's curator insight, June 11, 2013 6:57 PM

Naloxone not only saves lifes by reversing overdose - it will also saves surviving friends and family who assisted with injecting from going to prison for manslaughter

Scooped by Cindy Cárdenas
Scoop.it!

FDA OKs System for Testing 193 Yeasts & Bacteria Known to Cause Infections - ADVANCE for LPNs

FDA OKs System for Testing 193 Yeasts & Bacteria Known to Cause Infections ADVANCE for LPNs The FDA reviewed the VITEK MS through its de novo classification process, a regulatory pathway for some novel low-to-moderate risk medical devices that are...
more...
No comment yet.
Rescooped by Cindy Cárdenas from The Jazz of Innovation
Scoop.it!

Innovation Time

Innovation Time | Pharma | Scoop.it

For years we've talked about risk, uncertainty, culture and other factors that block innovation.  Increasingly, the biggest barrier is time.  Time is an innovation barrier on several levels. 


Via Peter Verschuere
more...
No comment yet.
Rescooped by Cindy Cárdenas from Digital Health
Scoop.it!

Big Data and Healthcare PR

Big Data and Healthcare PR | Pharma | Scoop.it
In the last few years, data has changed the landscape of the healthcare public relations (PR) industry where I work as a digital specialist. The change has been largely driven by the use of digital technologies and social media.

Via Alex Butler
more...
Dinesh Chindarkar's curator insight, June 18, 2013 2:53 AM

HealthPR will completely change looking at the way technology & emerging medias are shaping up. Time to relook into PR & communication strategies for health marketers!

Rescooped by Cindy Cárdenas from Pharma & Medical Devices
Scoop.it!

Is Big Pharma Learning From Its Late Stage R&D Setbacks?

Is Big Pharma Learning From Its Late Stage R&D Setbacks? | Pharma | Scoop.it
English: Chemical structure of fostamatinib disodium (tamatinib fosdium; R-788; NSC-745942; R-935788) (Photo credit: Wikipedia) Big Pharma hardly needs to be warned of the fickle nature of drug development, but the industry received a timely reminder...

Via Richard Meyer
more...
No comment yet.
Rescooped by Cindy Cárdenas from Liberty Revolution
Scoop.it!

FDA approves first GMO Flu Vaccine containing Reprogrammed Insect Virus

FDA approves first GMO Flu Vaccine containing Reprogrammed Insect Virus | Pharma | Scoop.it
via Jonathan Benson Global Research
A new vaccine for influenza has hit the market, and it is the first ever to contain genetically-modified (GM) proteins derived from insect cells. According to reports, the U.S.

Via Hans Gruen
more...
No comment yet.
Rescooped by Cindy Cárdenas from Breast Cancer News
Scoop.it!

FDA Clears Multicenter Trial of Treatment for Chemotherapy-related Hair Loss

FDA Clears Multicenter Trial of Treatment for Chemotherapy-related Hair Loss | Pharma | Scoop.it

"The FDA has approved initiation of a multicenter trial of the DigniCap System, a scalp-cooling device for chemotherapy-related hair loss. The trial is the second and final phase of study for the DigniCap System. A pilot study previously conducted by researchers at the University of California San Francisco and Wake Forest Baptist Medical Center found that the treatment was successful and well tolerated in the majority of women."


Via Susan Zager
more...
Susan Zager's comment, June 16, 2013 2:43 PM
Hi Mats. I switched the photo and put a DigniCap photo in. I hope it's tight now. Thanks for taking the time to show the information!
Susan Zager's comment, June 16, 2013 2:45 PM
Hi Mats. I switched the photo and put a DigniCap photo in. I hope it's right now. Thanks for taking the time to show the correct information.
Mats Carlsson's comment, June 17, 2013 4:14 AM
Still the same picture of the Penguin Cap Susan :-) Try this website. http://www.bloomberg.com/news/2011-01-25/baldness-in-cancer-victims-may-be-avoided-if-caps-in-testing-work-safely.html
Scooped by Cindy Cárdenas
Scoop.it!

New weight-loss drug available - CNN

New weight-loss drug available - CNN | Pharma | Scoop.it
Metro.us
New weight-loss drug available
CNN
(CNN) -- Nearly a year after receiving approval from the U.S. Food and Drug Administration, a new obesity drug will be available to certain patients by prescription, starting Tuesday.
more...
No comment yet.